231 related articles for article (PubMed ID: 11241758)
1. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.
Pazzaglia S; Mancuso M; Primerano B; Rebessi S; Biozzi G; Covelli V; Saran A
Mol Carcinog; 2001 Feb; 30(2):111-8. PubMed ID: 11241758
[TBL] [Abstract][Full Text] [Related]
2. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
3. Skin tumorigenesis by initiators and promoters of different chemical structures in lines of mice selectively bred for resistance (Car-r) or susceptibility (Car-s) to two-stage skin carcinogenesis.
Saran A; Pazzaglia S; Rebessi S; Bouthillier Y; Pioli C; Covelli V; Mouton D; Doria G; Biozzi G
Int J Cancer; 1999 Oct; 83(3):335-40. PubMed ID: 10495425
[TBL] [Abstract][Full Text] [Related]
4. Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7,12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate.
Park CB; Fukamachi K; Takasuka N; Han BS; Kim CK; Hamaguchi T; Fujita K; Ueda S; Tsuda H
Cancer Sci; 2004 Mar; 95(3):205-10. PubMed ID: 15016318
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
6. Further analysis of c-Ha-ras mutations in papillomas initiated by several polycyclic aromatic hydrocarbons and papillomas from uninitiated, promoter-treated skin in SENCAR mice.
DiGiovanni J; Beltrán L; Rupp A; Harvey RG; Gill RD
Mol Carcinog; 1993; 8(4):272-9. PubMed ID: 8280375
[TBL] [Abstract][Full Text] [Related]
7. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
[TBL] [Abstract][Full Text] [Related]
8. Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.
Abdel-Fattah R; Glick A; Rehman I; Maiberger P; Hennings H
Int J Cancer; 2006 Feb; 118(3):527-31. PubMed ID: 16094607
[TBL] [Abstract][Full Text] [Related]
9. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.
Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H
Mol Carcinog; 2000 Apr; 27(4):298-307. PubMed ID: 10747294
[TBL] [Abstract][Full Text] [Related]
10. The genetic control of chemically and radiation-induced skin tumorigenesis: a study with carcinogenesis-susceptible and carcinogenesis-resistant mice.
Pazzaglia S; Mancuso M; Rebessi S; Di Majo V; Tanori M; Biozzi G; Covelli V; Saran A
Radiat Res; 2002 Jul; 158(1):78-83. PubMed ID: 12071806
[TBL] [Abstract][Full Text] [Related]
11. Characterization of benzo[a]pyrene-initiated mouse skin papillomas for Ha-ras mutations and protein kinase C levels.
Colapietro AM; Goodell AL; Smart RC
Carcinogenesis; 1993 Nov; 14(11):2289-95. PubMed ID: 8242857
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.
Wei SJ; Chang RL; Merkler KA; Gwynne M; Cui XX; Murthy B; Huang MT; Xie JG; Lu YP; Lou YR; Jerina DM; Conney AH
Carcinogenesis; 1999 Sep; 20(9):1689-96. PubMed ID: 10469612
[TBL] [Abstract][Full Text] [Related]
13. Synergistic interaction between the non-phorbol ester-type promoter mirex and 12-O-tetradecanoylphorbol-13-acetate in mouse skin tumor promotion.
Meyer SA; Kim TW; Moser GJ; Monteiro-Riviere NA; Smart RC
Carcinogenesis; 1994 Jan; 15(1):47-52. PubMed ID: 8293547
[TBL] [Abstract][Full Text] [Related]
14. Further studies on the influence of initiation dose on papilloma growth and progression during two-stage carcinogenesis in SENCAR mice.
DiGiovanni J; Walker SE; Aldaz CM; Slaga TJ; Conti CJ
Carcinogenesis; 1993 Sep; 14(9):1831-6. PubMed ID: 8403206
[TBL] [Abstract][Full Text] [Related]
15. Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice.
Battalora MS; Conti CJ; Aldaz CM; Slaga TJ; Johnston DA; DiGiovanni J
Carcinogenesis; 1996 May; 17(5):955-60. PubMed ID: 8640943
[TBL] [Abstract][Full Text] [Related]
16. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
17. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
Shibata MA; Ward JM; Green JE; Merlino G
Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
[TBL] [Abstract][Full Text] [Related]
18. Non-melanoma skin cancer in mouse and man.
Schwarz M; Münzel PA; Braeuning A
Arch Toxicol; 2013 May; 87(5):783-98. PubMed ID: 23266722
[TBL] [Abstract][Full Text] [Related]
19. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
20. A multihit, multistage model of chemical carcinogenesis.
Owens DM; Wei S; Smart RC
Carcinogenesis; 1999 Sep; 20(9):1837-44. PubMed ID: 10469632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
